Home
|
Help
|
Contact
Sign in
WPRIM Management System>
DCMS
>
Chinese Journal of Urology
>
2020
>
41
>
5
Volume:
41
Issue:
5
1. Proposal and thinking of renaming type Ⅲ prostatitis to prostate-pelvic syndrome
Page:326—329
2. Research development of postoperative intravesical chemotherapy for upper tract urothelial carcinoma
Page:397—400
3. A multicenter clinical study of comparing the efficacy of two mid-urethral slings in the treatment of female stress urinary incontinence
Page:368—373
4. A comparative study of sexual function preservation after robot-assisted and laparoscopic radical cystectomy and orthotopic bladder reconstruction
Page:356—361
5. Research development of the therapy in patients with locally advanced upper tract urothelial carcinoma
Page:389—393
6. The application of adjuvant radiotherapy after radical nephroureterectomy in the treatment of upper tract urothelial carcinoma
Page:394—396
7. A case report of renal fibrosclerotic nodule with calcification
Page:385—386
8. A case report of transperineal ultrasound-guided transperineal prostate biopsy to diagnose an abdominoperineal resection patient
Page:387—388
9. Prognostic relevance of preoperative platelet-to-albumin ratio(PAR) in patients with upper urinary tract urothelial carcinoma
Page:341—347
10. Upper tract urothelial carcinoma: small field, outstanding achievements
Page:321—325
11. A missed diagnosis case with squamous cell carcinoma of renal pelvis
Page:382—384
12. Clinical analysis of squamous cell carcinoma of renal pelvis
Page:348—351
13. The diagnosis and treatment of primary adenocarcinoma of the upper urinary tract
Page:352—355
14. Construction of primary prostate cancer cell bank using conditional reprogramming cell technology
Page:374—381
15. The update interpretation of 2020 EAU prostate cancer guideline(Part Ⅱ)
Page:332—333
16. The update interpretation of 2020 EAU prostate cancer guideline(Part Ⅰ)
Page:330—331
17. Impact of tumor architecture on prognosis of patients with upper tract urothelial carcinoma
Page:334—340
18. 125I low-dose-rate prostate brachytherapy and radical prostatectomy in patients with prostate cancer
Page:362—367